Article By:
Terry Chrisomalis
Sunday, July 3, 2016 10:28 AM EDT
Under the terms of this bid Pfizer has agreed to acquire all of binds assets for a total of $20 million in an all cash-type transaction. The company has been in a rough spot in terms of developing its Accurins platform.